Clinical Trial Update: Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating cisplatin and gemcitabine with or without bevacizumab in EGFR wild-type non-small cell lung cancer; current status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN